Clinical Fellow – Stereotactic Ablative Body Radiotherapy
| Dyddiad hysbysebu: | 26 Medi 2025 |
|---|---|
| Cyflog: | £52,656.00 i £73,992.00 bob blwyddyn |
| Gwybodaeth ychwanegol am y cyflog: | £52656.00 - £73992.00 a year |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 10 Hydref 2025 |
| Lleoliad: | Manchester, M20 4BX |
| Cwmni: | NHS Jobs |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | C9413-25-0667 |
Crynodeb
The successful applicant would be expected to work alongside consultants and trainees in outpatient clinics across a number of disease groups, supervising Technical Radiotherapy delivery andperforming on-treatment reviews and follow-up assessments.The role will be responsible for: The appointee will be a Fellow in the department of Clinical Oncology The employing authority is The Christie NHS Foundation Trust S/he will be managerially accountable to the Clinical Director of the Directorate of ClinicalOncology S/he will be professionally responsible to the consultants in whose clinics s/he will besupporting. The post-holder will be assigned a clinical supervisor (Consultant Clinical Oncologist). Theywill work alongside their supervisor in at least one clinic. Will develop expertise in the development, management and treatment of HPB andoligometastatic tumour sites with SABR The Clinical Oncology establishment currently consists of 59 Consultants who run the clinical service and research practice. There is also a team of 24 SpRs plus Academic and Clinical Fellows. The appointee will be based at The Christie and will provide senior input to all aspects of the management of patients with HBT and oligometastatic disease. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, technical radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated SABR team consultant.